Skip to main content
Clinical Trials/NCT05480644
NCT05480644
Recruiting
Not Applicable

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Duke University1 site in 1 country300 target enrollmentDecember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Tumor, Primary
Sponsor
Duke University
Enrollment
300
Locations
1
Primary Endpoint
Number of circulating immune cells in peripheral blood
Status
Recruiting
Last Updated
5 months ago

Overview

Brief Summary

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.

Detailed Description

Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.

Registry
clinicaltrials.gov
Start Date
December 1, 2022
End Date
December 1, 2032
Last Updated
5 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Have a confirmed diagnosis of primary or metastatic brain tumor (histology or imaging as appropriate)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of circulating immune cells in peripheral blood

Time Frame: 6 weeks post radiation therapy

reported as mean +/- standard deviation

Study Sites (1)

Loading locations...

Similar Trials